Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Mesenchymal stem/stromal cells may decrease success of cancer treatment by inducing resistance to chemotherapy in cancer cells
ID
Železnik Ramuta, Taja
(
Author
),
ID
Erdani-Kreft, Mateja
(
Author
)
PDF - Presentation file,
Download
(936,72 KB)
MD5: E86C60377EF360EAE091A95089F47BEC
URL - Source URL, Visit
https://www.mdpi.com/2072-6694/14/15/3761
Image galllery
Abstract
The tumour microenvironment, which is comprised of various cell types and the extracellular matrix, substantially impacts tumour initiation, progression, and metastasis. Mesenchymal stem/stromal cells (MSCs) are one of the key stromal cells in the tumour microenvironment, and their interaction with cancer cells results in the transformation of naïve MSCs to tumour-associated MSCs. The latter has an important impact on tumour growth and progression. Recently, it has been shown that they can also contribute to the development of chemoresistance in cancer cells. This review provides an overview of 42 studies published between 1 January 2001 and 1 January 2022 that examined the effect of MSCs on the susceptibility of cancer cells to chemotherapeutics. The studies showed that MSCs affect various signalling pathways in cancer cells, leading to protection against chemotherapy-induced damage. Promising results emerged from the use of inhibitors of various signalling pathways that are affected in cancer cells due to interactions with MSCs in the tumour microenvironment. These studies present a good starting point for the investigation of novel treatment approaches and demonstrate the importance of targeting the stroma in the tumour microenvironment to improve treatment outcomes.
Language:
English
Keywords:
mesenchymal stem/stromal cells
,
tumour microenvironment
,
cancer therapy
,
tumour stroma
,
cancers
,
drug resistance
Work type:
Article
Typology:
1.02 - Review Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2022
Number of pages:
35 str.
Numbering:
Vol. 14, iss. 15, art. 3761
PID:
20.500.12556/RUL-145232
UDC:
616-006
ISSN on article:
2072-6694
DOI:
10.3390/cancers14153761
COBISS.SI-ID:
117384707
Publication date in RUL:
13.04.2023
Views:
670
Downloads:
112
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Cancers
Shortened title:
Cancers
Publisher:
MDPI
ISSN:
2072-6694
COBISS.SI-ID:
517914137
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
mezenhimske matične/stromalne celice
,
tumorsko mikrookolje
,
zdravljenje raka
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
J7-2594
Name:
Uporaba amnijske membrane za inovativno multimodalno zdravljenje bakterijskega cistitisa in raka sečnega mehurja: učinek njene protimikrobne, imunomodulatorne in protirakave aktivnosti
Funder:
ARRS - Slovenian Research Agency
Project number:
J3-2526
Name:
Razkrivanje niše matičnih glioma celic v iskanju novih terapevtskih ciljev pri bolnikih z glioblastomom
Funder:
ARRS - Slovenian Research Agency
Project number:
P3-0108
Name:
Diferenciacija urotelijskih celic
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back